Showing results (31-40 of 459) with videos related to
Sort By:
Pageof 46
Psychiatry Research|October 16, 1996
Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteersM Maes, H Y MeltzerThe Journal of Clinical Psychiatry|May 26, 1999
Low-dose loxapine in the treatment of schizophrenia: is it more effective and more "atypical" than standard-dose loxapine?H Y Meltzer, K JayathilakeBrain Research|November 6, 1995
DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatumJ Ichikawa, H Y MeltzerPsychiatry Research|September 29, 1995
Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal menH Y Meltzer, M MaesJournal of Neurochemistry|June 1, 1992
Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbensJ Ichikawa, H Y MeltzerEuropean Journal of Pharmacology|October 15, 1979
Repeated administration of 5-methoxy-N,N-dimethyltryptamine to male rats potentiates stimulation of prolactin secretion by serotonin agonistsM Simonovic, H Y MeltzerBiological Psychiatry|March 1, 1994
Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjectsH Y Meltzer, M MaesBrain Research|January 15, 1990
Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatmentJ Ichikawa, H Y MeltzerEuropean Journal of Pharmacology|December 3, 1982
Effect of chronic phencyclidine or d-amphetamine treatment on [3H]spiroperidol binding in rat caudate-putamen and nucleus accumbensM Daiguji, H Y MeltzerEuropean Archives of Psychiatry and Clinical Neuroscience|February 2, 2000
Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugsJ Ichikawa, H Y MeltzerPageof 46